High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients

Psychopharmacology

Volumn 81, Issue 1, 1983, Pages 42-47

  Nestoros, J N ^a   Nair, N P V ^a   Pulman, J R ^a   Schwartz, G ^a   Bloom, D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Clinical trial; Diazepam; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DIAZEPAM; DOPAMINE; FLUPHENAZINE; HALOPERIDOL; PLACEBO; TRIFLUOPERAZINE;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; HUMAN; MENTAL HEALTH; SCHIZOPHRENIA; SEDATION; THERAPY;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DIAZEPAM; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0020544416     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00439272     Document Type: Article

References (28)

1. Effects of γ-hydroxybutyric acid, baclofen, aminoxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system
2. Some effects of GABA and GABA-like drugs on central catecholamine mechanisms
3. High-dose diazepam in schizophrenia
4. Antipsychotic drugs, neurotransmitters, and schizophrenia
5. Effect of GABA administered intracerebroventricularly or intraperitoneally on brain monoamines and locomotor activity
6. GABAergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat
7. Molecular mechanisms in the receptor action of benzodiazepines
8. Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound
9. Antipsychotic drugs
10. Baclofen in schizophrenia
11. GABA neurons and their interaction with monoamine neurons: An anatomical, pharmacological and functional analysis
12. Diazepam in schizophrenia: A preliminary double-blind trial
13. Sodium valproate in schizophrenia: Some biochemical correlates
14. The psychotic inpatient profile: A nurse's observation scale
15. The dopamine hypothesis of schizophrenia: A review
16. Benzodiazepines in schizophrenia.: A need for reassessment
17. The Brief Psychiatric Rating Scale
18. Evidence for the involvement of dopamine in the action of diazepam: Potentiation of haloperidol and chlorpromazine action in the brain
19. Prospects for research on schizophrenia: An hypothesis suggesting that there is a defect in the GABA system in schizophrenia
20. Dislnhibition as an organizing principle in the nervous system: The role of the GABA system Application to neurologic and psychiatric disorders
21. Baclofen in schizophrenia
22. Catecholamines in the brain as mediators of amphetamine psychosis
23. Muscimol: GABA agonist therapy in schizophrenia
24. γ-Aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia
25. Achons of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat